[F31] Sex hormones that control antibody class switching to IgG
Ente: National Institute of Allergy and Infectious Diseases
Scadenza: 2029-04-30
Importo max: 38.280 EUR
Paese: US
Descrizione
Project Summary
As a PhD candidate in the Lingwood laboratory at the Ragon institute of Mass General, MIT and Harvard, I
propose to mechanistically define how B cell class switch recombination (CSR), a core immune reaction
underscoring all humoral immunity (e.g. IgM -> IgG), is modulated by sex differences in hormones and circulating
cytokines. Adaptive immunity, including the generation of IgG, is often elevated in females, however mechanistic
reasons are lacking. In preliminary data, I find that the circulating levels of APRIL, a cytokine that stimulates CSR
independently of conventional T cell help, is higher in female as compared in male mice. This correlates with
heightened APRIL signaling in human females. Antibody responses to T cell/thymus-independent (TI) antigens
(non-protein pathogen features such as bacterial glycan polymers and lipids) are dependent on ligation of the
APRIL receptor TACI and I demonstrate that IgG switching within this pathway is correspondingly higher in
females. The sex differences in both APRIL and IgG switching can be reversed by male gonadectomy (GDX) to
remove circulating testosterone. I will now test the central hypothesis that test the central hypothesis that
testosterone suppresses APRIL, lowering the class switched IgG in response. In Aim 1 I will apply
orthogonal methods to experimentally alter circulating levels of APRIL and/or testosterone in mice to assess
hormone feedback on APRIL and control over IgG switching within the TACI-dependent TI-response pathway. In
Aim 2, I will deploy a model of bone marrow chimerism I have developed to stably engraft the host lymphoid
organs with sex-mismatched CD45+ leukocytes (macrophages, granulocytes, monocytes and T and B
lymphocytes). This system will experimentally distinguish cell intrinsic (e.g. XX vs XY) from environmental (testis
vs ovary) contributions to sex differences in TI antibody output. Overall, this proposal aims to rigorously define a
mechanism for sex-based control over B cell CSR, a core immune reaction that forms a basis of humoral
immunity.
Istituzione: HARVARD MEDICAL SCHOOL
PI: Lindsey Adams
Progetto: 1F31AI188593-01A1
Settori: National Institute of Allergy and Infectious Diseases
Vai al bando originale
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.